Literature DB >> 11558028

Endoscopic band ligation of Dieulafoy-like lesions in the upper gastrointestinal tract.

N Nikolaidis1, P Zezos, O Giouleme, K Budas, G Marakis, G Paroutoglou, N Eugenidis.   

Abstract

BACKGROUND AND STUDY AIMS: Endoscopic band ligation (EBL) is currently considered to be the treatment of choice for esophageal variceal bleeding. This study reports on the efficacy and safety of EBL in patients with Dieulafoy-like bleeding lesions in the upper gastrointestinal tract. PATIENTS AND METHODS: Between December 1994 and February 2000, 23 patients with upper gastrointestinal tract hemorrhage (median age 58, range 28-75) were treated using EBL. EBL was used as a rescue therapy in four patients and as the initial treatment in 19 patients.
RESULTS: The site of bleeding was the stomach in 10 patients, Billroth II anastomosis in 10, the first part of the duodenum in one, the second part of the duodenum in one, and the jejunum in one patient. Endoscopic band ligation was successful in 22 of the 23 patients. The remaining patient, a young man with a Dieulafoy-like lesion in the jejunum, had recurrent bleeding on day 5 after EBL and underwent elective surgery.
CONCLUSIONS: Endoscopic band ligation is an effective and safe endoscopic treatment for Dieulafoy-like lesions. It is easy to use and relatively inexpensive.

Entities:  

Mesh:

Year:  2001        PMID: 11558028     DOI: 10.1055/s-2001-16522

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  21 in total

1.  Double Dieulafoy-like lesion in the stomach.

Authors:  P Katsinelos; G Paroutoglou; I Pilpilidis; P Tsolkas; A Papagiannis; P Kapelidis; C Trakateli; A Iliadis; E Georgiadou; E Kamperis; S Dimiropoulos; I Vasiliadis
Journal:  Surg Endosc       Date:  2003-06-13       Impact factor: 4.584

2.  Upper gastrointestinal dieulafoy's lesions and endoscopie treatment: first report from a mexican centre.

Authors:  Gustavo López-Arce; Sergio Zepeda-Gómez; Norberto C Chávez-Tapia; Sandra Garcia-Osogobio; Ada M Franco-Guzmán; Miguel A Ramirez-Luna; Félix I Téllez-Ávila
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

3.  Dieulafoy's lesion: a case series study.

Authors:  R S Walmsley; Yuk-Tong Lee; Joseph J Y Sung
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

4.  Actively bleeding Dieulafoy's lesion of the small bowel identified by capsule endoscopy and treated by push enteroscopy.

Authors:  Giovanni D De Palma; Francesco Patrone; Maria Rega; Immacolata Simeoli; Stefania Masone; Giovanni Persico
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

5.  Outcomes in Dieulafoy's Lesion: A 10-Year Clinical Review.

Authors:  Rajan Kanth; Padmavathi Mali; Praveen K Roy
Journal:  Dig Dis Sci       Date:  2015-02-08       Impact factor: 3.199

Review 6.  Gastrointestinal bleeding from Dieulafoy's lesion: Clinical presentation, endoscopic findings, and endoscopic therapy.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

7.  Dieulafoy-like lesion bleeding: in the loop.

Authors:  Pragnesh Patel; Martin Tobi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

8.  Endoscopic banding ligation can effectively remove the submucosal tumor.

Authors:  Fei-Zhen Xia; Zhe Shen; Hong-Tan Chen; Chao-Hui Yu; Wei-Xing Chen
Journal:  Int J Clin Exp Med       Date:  2015-01-15

9.  A case of rectal Dieulafoy's ulcer and successful endoscopic band ligation.

Authors:  Yukako Yoshikumi; Hirosato Mashima; Junko Suzuki; Yutaka Yamaji; Makoto Okamoto; Keiji Ogura; Takao Kawabe; Masao Omata
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

10.  Prognostic factors for recurrence of gastrointestinal bleeding due to Dieulafoy's lesion.

Authors:  Yuliana Jamanca-Poma; Antonio Velasco-Guardado; Concepción Piñero-Pérez; Renzo Calderón-Begazo; Josue Umaña-Mejía; Fernando Geijo-Martínez; Antonio Rodríguez-Pérez
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.